Milestone Pharmaceuticals Inc. (MIST) › Net IncomeMilestone Pharmaceuticals Inc. (MIST) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$23.18M2019: -$55.23M2020: -$49.97M2021: -$42.85M2022: -$58.39M2023: -$59.69M2024: -$41.52M2025: -$63.06M-$63.06M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$63.06M-51.9%2024-$41.52M+30.4%2023-$59.69M-2.2%2022-$58.39M-36.3%2021-$42.85M+14.2%2020-$49.97M+9.5%2019-$55.23M-138.2%2018-$23.18M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share